Public recall detail

JAMP ATORVASTATIN CALCIUM: Affected lot may be labelled with the incorrect strength on the label.

2022-08-29

medium
Recall Safety notice
Quick summary

Quick summary: JAMP ATORVASTATIN CALCIUM: Affected lot may be labelled with the incorrect strength on the label.. Date: 2022-08-29.

Recommended action

Recommended action: compare your product with the official notice and follow the instructions published by the official source.

Recall details

Quick summary: JAMP ATORVASTATIN CALCIUM: Affected lot may be labelled with the incorrect strength on the label.. Date: 2022-08-29.

Official details

Affected product details

Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.

BrandJAMP ATORVASTATIN CALCIUM
ProductJAMP ATORVASTATIN CALCIUM
IssueHealth products - Dosage Health products - Labelling
Recall classType I
IdentificationRA-64512

Affected products

BrandJAMP ATORVASTATIN CALCIUM
ProductJAMP ATORVASTATIN CALCIUM 10 mg
DIN / NPN / authorizationDIN 02504197
Dosage formTablet
StrengthATORVASTATIN (ATORVASTATIN CALCIUM) 10 MG
LotD10776B
BrandJAMP ATORVASTATIN CALCIUM
ProductJAMP ATORVASTATIN CALCIUM 40 mg
DIN / NPN / authorizationDIN 02504219
Dosage formTablet
StrengthATORVASTATIN (ATORVASTATIN CALCIUM) 40 MG
LotD10776B

Issue

Jamp Pharma Corporation is recalling one lot (D10776B) of Jamp-Atorvastatin Calcium after one bottle labelled to contain 10 mg tablets of Jamp-Atorvastatin Calcium was found to contain 40 mg tablets of Jamp-Atorvastatin Calcium. Pharmacists may not recognize the error and accidentally repackage and dispense bottles to patients that are labelled as 10 mg atorvastatin calcium tablets (DIN 02504197), but incorrectly contain 40 mg atorvastatin calcium tablets. Product from the affected lot was sold to pharmacies between May 2022 and August 2022. Both the 10 mg and 40 mg atorvastatin calcium tablets are similar-looking white and oval shaped tablets; however, the 10 mg tablets have a "10" marked on one side while the 40 mg tablets have a "40" marked on one side. Atorvastatin calcium is a prescription drug in the class of statins used to lower cholesterol and other fats in the blood and for prevention of cardiovascular disease such as heart attacks. Taking too much atorvastatin calcium or more than the prescribed amount for a long period of time (i.e., taking 40 mg of atorvastatin calcium instead of 10 mg atorvastatin calcium) can increase the risk of serious adverse events, including muscle pain or muscle weakness (i.e., rhabdomyolysis, a rare but serious adverse event associated with statins). The Department is monitoring the company's recall and will inform the public if any new health risks are identified.

What you should do

  • Check your bottle of Jamp-Atorvastatin Calcium, 10 mg tablets to make sure it contains 10 mg tablets and not 40 mg tablets. 10 mg atorvastatin calcium tablets are white to off-white, oval shaped, film-coated tablets, with "10" marked on one side and "AT" marked on the other. 40 mg atorvastatin calcium tablets are white to off-white, oval shaped, film-coated tablets, with "40" marked on one side and "AT" marked on the other.
  • If you are unsure, contact your pharmacist to check if your bottle of Jamp-Atorvastatin Calcium contains the correct tablets.
  • If you see incorrect tablets, stop taking the medication and contact your pharmacy immediately for a replacement product. Return the affected product to your pharmacy for proper disposal.
  • Seek medical attention immediately if you experience any serious adverse effects from atorvastatin calcium which may include muscle pain or muscle weakness.
  • Contact Jamp Pharma Corporation by calling toll-free at 1-866-399-9091, extension 501, or by email at serviceclient@jamppharma.com, if you have questions about this recall.
  • Report any health product adverse events or complaints to Health Canada.
Additional official information
AudienceGeneral public Healthcare Industry Retail
CategoryHealth products - Drugs
CompaniesJAMP PHARMA CORPORATION 1310 Rue Nobel, Boucherville Quebec, J4B 5H3
Published byHealth Canada
Recall classType I
Alert / recall typeHealth product recall
Identification numberRA-64512
Background{}
CompaniesJAMP PHARMA CORPORATION 1310 Rue Nobel, Boucherville Quebec, J4B 5H3
AudiencesGeneral public Healthcare Industry Retail
Source updated2022-08-29

Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.

Starting...

Related recalls

Similar recalls and safety notices.

Loading related recalls...